Gilead Sciences (GILD) Declares $0.57 Quarterly Dividend; 3.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Intel shares fall as competitor reports record results
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Gilead Sciences (GILD) PT Lowered to $87 at RBC Capital
October 26, 2018 7:24 AM EDTRBC Capital analyst Brian Abrahams lowered the price target on Gilead Sciences (NASDAQ: GILD) to $87.00 (from $89.00) while maintaining a Outperform rating.
... MoreGilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance
October 25, 2018 4:06 PM EDTGilead Sciences (NASDAQ: GILD) reported Q3 EPS of $1.84, $0.21 better than the analyst estimate of $1.63. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.38 billion.
GUIDANCE:
Gilead Sciences sees Q4 2018 revenue of $20.8-21.3 billion, versus the consensus of... More



